BioMarin Pharmaceutical
BMRN
$74.30
Share price
-1.62%
Change (1 day)
-16.04%
Change (1 year)
Categories
BioMarin Pharmaceutical (BMRN) - P/B ratio
P/B ratio as of May 2024 : 2.83
According to BioMarin Pharmaceutical's latest financial reports the company has a price-to-book ratio of 2.83.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
BioMarin Pharmaceutical - P/B ratio (from 2001 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 3.67 | -12.21% |
| 2022-12-31 | 4.18 | 9.88% |
| 2021-12-31 | 3.80 | -1.92% |
| 2020-12-31 | 3.88 | -20.39% |
| 2019-12-31 | 4.87 | -4.78% |
| 2018-12-31 | 5.11 | -8.28% |
| 2017-12-31 | 5.58 | 8.26% |
| 2016-12-31 | 5.15 | -26.93% |
| 2015-12-31 | 7.05 | -20.1% |
| 2014-12-31 | 8.82 | 17.21% |
| 2013-12-31 | 7.53 | 23.5% |
| 2012-12-31 | 6.09 | 19.97% |
| 2011-12-31 | 5.08 | 22.28% |
| 2010-12-31 | 4.15 | -29.53% |
| 2009-12-31 | 5.89 | -8.22% |
| 2008-12-31 | 6.42 | -64.93% |
| 2007-12-31 | 18.3 | 43.5% |
| 2006-12-31 | 12.8 | -223.42% |
| 2005-12-31 | -10.3 | 70.54% |
| 2004-12-31 | -6.06 | -243.53% |
| 2003-12-31 | 4.22 | 9.79% |
| 2002-12-31 | 3.85 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | 1.48 | -47.50% | 🇫🇷 France |
 Ultragenyx RARE | 23.9 | 745.98% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | 2.18 | -22.92% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -1.37 | -148.52% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | 21.9 | 674.64% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | 3.34 | 18.14% | 🇺🇸 USA |